Kiora Pharmaceuticals Inc...

NASDAQ: KPRX · Real-Time Price · USD
2.93
0.40 (15.81%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.71%
After-hours: Aug 15, 2025, 07:12 PM EDT

Kiora Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.15M -2.19M -4.22M -3.41M -2.22M 13.45M -2.27M -5.76M -2.61M -1.87M -2.5M -5.12M -2.4M -3.57M -8.38M -2.97M -2.47M -2.58M
Depreciation & Amortization
3.42K 19.61K 17.39K 2.1K 17.88K 16.21K 7.93K 11.31K 22.48K 10.08K 10.29K 10.27K 10.28K 10.77K 11.04K 11.06K 12.6K 10.6K
Stock-Based Compensation
262.77K 148.62K 160.18K 171.18K 149.79K 175.44K 182.34K 264.86K 171.79K 135.94K 45.12K 130.15K 71.25K 215.92K 213.17K 149.47K 262.89K 216.94K
Other Working Capital
-376.7K -922.78K 2.36M 194.15K -27.14K -121.97K -118.36K 77.05K 1.36M 355.63K 322.64K 228.45K -714K 83.51K -477.34K 356.5K -325.44K -278.85K
Other Non-Cash Items
155.39K 251.24K -21.04K 861.79K 48.35K -12.19K 13.51K 1.54M 177.84K 241.7K -42.9K 1.79M 69.08K 280.78K 5.83M 47.13K 46.9K 39.49K
Deferred Income Tax
n/a n/a -288.75K n/a n/a n/a 90.32K 1.9M n/a n/a -113.01K n/a n/a n/a -304.78K n/a n/a n/a
Change in Working Capital
-2.07M -930.68K 2.1M 3.3M -1.73M -7.81K -606.84K -483.12K 856.78K -1.59M 469.95K 222.16K -248.75K 225.15K -778.13K 489.06K -490.47K -256.26K
Operating Cash Flow
-3.8M -2.7M -2.25M 920.06K -3.73M 13.62M -2.58M -2.52M -1.38M -3.07M -2.13M -2.97M -2.5M -2.83M -3.41M -2.27M -2.64M -2.57M
Capital Expenditures
-32.2K n/a 45.03K 3.00 -51.29K 5.00 n/a -3 n/a n/a n/a n/a n/a n/a 63.87K n/a -5.75K -58.12K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.38K -93.16K n/a n/a n/a
Purchase of Investments
-4.56M -3.62M -6.54M -7.8M -21.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
5.25M 6.29M 6.98M 5.88M 115.65K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -236 n/a n/a n/a 6.38K n/a n/a 6.38K -63.87K n/a n/a n/a
Investing Cash Flow
664.17K 2.67M 482.68K -1.92M -21.22M n/a -236 n/a n/a n/a 6.38K n/a n/a 6.38K -93.16K n/a -5.75K -58.12K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 278.19K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a 1.19M -1.19M n/a n/a n/a n/a -15.63K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 15M n/a -939.53K 1.44M 318.32K 813.32K -813.32K 298.5K 3.26M -505.02K n/a n/a -1M n/a -278.19K 50K
Financial Cash Flow
265.36K n/a n/a n/a 250.52K 15.25M -486.42K n/a 5.94M 513.17K 3.24M 5.38M n/a n/a 278.19K 9.76M -278.19K 8.04M
Net Cash Flow
-2.74M -21.27K -1.85M -938.03K -24.7M 28.82M -2.95M -2.55M 4.53M -2.58M 1.16M 2.37M -2.64M -2.79M -3.25M 7.44M -2.95M 5.42M
Free Cash Flow
-3.84M -2.7M -2.21M 920.06K -3.78M 13.62M -2.58M -2.52M -1.38M -3.07M -2.13M -2.97M -2.5M -2.83M -3.35M -2.27M -2.64M -2.63M